National Campaign Shows Allergy Sufferers How to Put Their Best Face Forward

Celebrity Makeup Artist and Renowned Allergist Provide

Insight Into Feeling Good and Looking Great



Apr 04, 2001, 01:00 ET from Aventis Pharmaceuticals

    BRIDGEWATER, N.J., April 4 /PRNewswire/ -- For many seasonal allergy
 sufferers, the symptoms of runny noses and itchy, watery red eyes can cause
 swelling and redness around the eyes and nose.  Celebrity makeup artist, Paula
 Dorf, and Michael Kaliner, M.D., Medical Director at the Institute for Asthma
 and Allergy at Washington Hospital Center, are encouraging millions of women
 to join them in "Making Up for Allergies" this spring.  As part of this
 nationwide campaign, Dorf and Kaliner are offering practical advice about
 medical treatment and cosmetic techniques to help women manage their allergies
 this spring.
     The "Making Up for Allergies" campaign includes an online brochure
 developed by Paula Dorf with her most effective tips for minimizing the
 unsightly effects of allergies on one's appearance.  Consumers will be able to
 view her tips as well as other information about allergies and effective
 treatment options by visiting http://www.allergymakeup.com.
     "The best way to manage the irritation and discomfort of allergies is to
 not suffer with the symptoms at all," said Dr. Kaliner.  "Allergy sufferers
 should see their doctors before the peak of spring allergy season to seek
 treatment with a nonsedating prescription antihistamine."
     While the key to preventing itchy, watery red eyes and a runny nose starts
 with proper allergy treatment, Dorf's practical makeup tips can minimize these
 unsightly effects.
     "Many of my clients with allergies need a quick fix to help conceal the
 condition's effect on their appearance," said Dorf, who recommends the
 following simple tips to help them put their best face forward:
 
     *     Avoid alcohol-based toners and use a moisturizer with Vitamin E,
           especially around the nose and eyes, to hide broken capillaries and
           reduce the appearance of dark circles.
     *     Use mascara to "open up" and give a lift to itchy, watery and puffy
           eyes.  Also, curled lashes draw attention upward, making eyes look
           less droopy.
     *     To help direct attention away from puffiness caused by rubbing itchy
           eyes, use a light textured cream with a tint of color to smooth and
           neutralize the eyelid.
     *     To brighten your mood and your outlook, always wear lipstick!
 
     Seasonal allergies, commonly referred to as "hay fever," is a chronic and
 recurrent condition occurring during the spring and fall allergy seasons that
 is caused by the body's reaction to allergens entering the respiratory tract.
 Typical allergens that cause seasonal allergies are grass, tree and weed
 pollens.  Symptoms typically affect the nose, but patients also report itchy,
 watery eyes and sneezing.
     The symptoms of seasonal allergies can be managed effectively with
 prescription nonsedating antihistamines such as Allegra(R) (fexofenadine HCl),
 which does not cause the drowsy feeling you can get from some other allergy
 medicines.  Allegra(R) 180 mg once-daily tablets provide fast, powerful, safe
 and effective relief of seasonal allergies in patients 12 years and older.
 
     Allegra(R) (fexofenadine HCl)
     Allegra 180 milligram (mg) tablets once daily is indicated for the
 treatment of symptoms in patients 12 years and older who have seasonal
 allergies/seasonal allergic rhinitis (SAR).
     The most commonly reported adverse events with Allegra(R) (fexofenadine
 HCl) 180 mg and placebo, respectively, in SAR patients 12 years and older are
 headache (10.6 percent vs. 7.5 percent), upper respiratory tract infection
 (3.2 percent vs. 3.1 percent), and back pain (2.8 percent vs. 1.4 percent).
 
     Aventis Pharmaceuticals
     Aventis Pharmaceuticals conducts the U.S. business of Aventis Pharma AG,
 the pharmaceutical company of Aventis S.A. (NYSE:   AVE).  Aventis
 Pharmaceuticals, with U.S. headquarters in Bridgewater, N.J., focuses its
 activities on important therapeutic areas such as cardiology, oncology,
 anti-infectives, arthritis, allergy and respiratory, diabetes and the central
 nervous system.
     Aventis Pharma is dedicated to treating and preventing human disease
 through the discovery, development, manufacture and sale of innovative
 pharmaceutical products aimed at fulfilling unmet medical needs.  The
 corporate headquarters of Aventis Pharma is in Frankfurt, Germany.  Aventis
 Pharma comprises Aventis Pasteur, a world leader in vaccines, with corporate
 headquarters in Lyon, France, and Aventis Behring, a world leader in
 therapeutic proteins, with corporate headquarters in King of Prussia, P.A.
     Aventis S.A., one of the world's leading life sciences companies, is
 focused on two core business areas:  pharmaceuticals and agriculture.  With
 global corporate headquarters in Strasbourg, France, Aventis employs around
 90,000 people in 120 countries.
     Aventis was launched in December 1999 through the merger of Hoechst AG and
 Rhone-Poulenc S.A.
 
     To receive a copy of this release or any recent release via fax, call
 Aventis Pharmaceuticals' automated news fax line at 816-966-3434.  See
 enclosed prescribing information or to receive prescribing information, call
 800-552-3656 or visit the Aventis Pharmaceuticals U.S. Web site at
 http://www.aventispharma-us.com.
 
     Statements in this news release other than historical information are
 forward-looking statements subject to risks and uncertainties.  Actual results
 could differ materially depending on factors such as the availability of
 resources, the timing and effects of regulatory actions, the strength of
 competition, the outcome of litigation and the effectiveness of patent
 protection.  Additional information regarding risks and uncertainties is set
 forth in the current Annual Report on Form 20-F of Aventis on file with the
 Securities and Exchange Commission.
 
     0689C1
 
 

SOURCE Aventis Pharmaceuticals
    BRIDGEWATER, N.J., April 4 /PRNewswire/ -- For many seasonal allergy
 sufferers, the symptoms of runny noses and itchy, watery red eyes can cause
 swelling and redness around the eyes and nose.  Celebrity makeup artist, Paula
 Dorf, and Michael Kaliner, M.D., Medical Director at the Institute for Asthma
 and Allergy at Washington Hospital Center, are encouraging millions of women
 to join them in "Making Up for Allergies" this spring.  As part of this
 nationwide campaign, Dorf and Kaliner are offering practical advice about
 medical treatment and cosmetic techniques to help women manage their allergies
 this spring.
     The "Making Up for Allergies" campaign includes an online brochure
 developed by Paula Dorf with her most effective tips for minimizing the
 unsightly effects of allergies on one's appearance.  Consumers will be able to
 view her tips as well as other information about allergies and effective
 treatment options by visiting http://www.allergymakeup.com.
     "The best way to manage the irritation and discomfort of allergies is to
 not suffer with the symptoms at all," said Dr. Kaliner.  "Allergy sufferers
 should see their doctors before the peak of spring allergy season to seek
 treatment with a nonsedating prescription antihistamine."
     While the key to preventing itchy, watery red eyes and a runny nose starts
 with proper allergy treatment, Dorf's practical makeup tips can minimize these
 unsightly effects.
     "Many of my clients with allergies need a quick fix to help conceal the
 condition's effect on their appearance," said Dorf, who recommends the
 following simple tips to help them put their best face forward:
 
     *     Avoid alcohol-based toners and use a moisturizer with Vitamin E,
           especially around the nose and eyes, to hide broken capillaries and
           reduce the appearance of dark circles.
     *     Use mascara to "open up" and give a lift to itchy, watery and puffy
           eyes.  Also, curled lashes draw attention upward, making eyes look
           less droopy.
     *     To help direct attention away from puffiness caused by rubbing itchy
           eyes, use a light textured cream with a tint of color to smooth and
           neutralize the eyelid.
     *     To brighten your mood and your outlook, always wear lipstick!
 
     Seasonal allergies, commonly referred to as "hay fever," is a chronic and
 recurrent condition occurring during the spring and fall allergy seasons that
 is caused by the body's reaction to allergens entering the respiratory tract.
 Typical allergens that cause seasonal allergies are grass, tree and weed
 pollens.  Symptoms typically affect the nose, but patients also report itchy,
 watery eyes and sneezing.
     The symptoms of seasonal allergies can be managed effectively with
 prescription nonsedating antihistamines such as Allegra(R) (fexofenadine HCl),
 which does not cause the drowsy feeling you can get from some other allergy
 medicines.  Allegra(R) 180 mg once-daily tablets provide fast, powerful, safe
 and effective relief of seasonal allergies in patients 12 years and older.
 
     Allegra(R) (fexofenadine HCl)
     Allegra 180 milligram (mg) tablets once daily is indicated for the
 treatment of symptoms in patients 12 years and older who have seasonal
 allergies/seasonal allergic rhinitis (SAR).
     The most commonly reported adverse events with Allegra(R) (fexofenadine
 HCl) 180 mg and placebo, respectively, in SAR patients 12 years and older are
 headache (10.6 percent vs. 7.5 percent), upper respiratory tract infection
 (3.2 percent vs. 3.1 percent), and back pain (2.8 percent vs. 1.4 percent).
 
     Aventis Pharmaceuticals
     Aventis Pharmaceuticals conducts the U.S. business of Aventis Pharma AG,
 the pharmaceutical company of Aventis S.A. (NYSE:   AVE).  Aventis
 Pharmaceuticals, with U.S. headquarters in Bridgewater, N.J., focuses its
 activities on important therapeutic areas such as cardiology, oncology,
 anti-infectives, arthritis, allergy and respiratory, diabetes and the central
 nervous system.
     Aventis Pharma is dedicated to treating and preventing human disease
 through the discovery, development, manufacture and sale of innovative
 pharmaceutical products aimed at fulfilling unmet medical needs.  The
 corporate headquarters of Aventis Pharma is in Frankfurt, Germany.  Aventis
 Pharma comprises Aventis Pasteur, a world leader in vaccines, with corporate
 headquarters in Lyon, France, and Aventis Behring, a world leader in
 therapeutic proteins, with corporate headquarters in King of Prussia, P.A.
     Aventis S.A., one of the world's leading life sciences companies, is
 focused on two core business areas:  pharmaceuticals and agriculture.  With
 global corporate headquarters in Strasbourg, France, Aventis employs around
 90,000 people in 120 countries.
     Aventis was launched in December 1999 through the merger of Hoechst AG and
 Rhone-Poulenc S.A.
 
     To receive a copy of this release or any recent release via fax, call
 Aventis Pharmaceuticals' automated news fax line at 816-966-3434.  See
 enclosed prescribing information or to receive prescribing information, call
 800-552-3656 or visit the Aventis Pharmaceuticals U.S. Web site at
 http://www.aventispharma-us.com.
 
     Statements in this news release other than historical information are
 forward-looking statements subject to risks and uncertainties.  Actual results
 could differ materially depending on factors such as the availability of
 resources, the timing and effects of regulatory actions, the strength of
 competition, the outcome of litigation and the effectiveness of patent
 protection.  Additional information regarding risks and uncertainties is set
 forth in the current Annual Report on Form 20-F of Aventis on file with the
 Securities and Exchange Commission.
 
     0689C1
 
 SOURCE  Aventis Pharmaceuticals